Ann Rheum Dis 2001;60:619-626 ( June )

Extended report

Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage P Garnero^{a b}, M Piperno^c, E Gineyts^a, S Christgau^d, P D Delmas^a, E Vignon^c

^a Inserm Research Unit 403, Lyon, France, ^b Synarc, Lyon, France, ^c Service de Rhumatologie, Centre Hospitalier Lyon Sud, Lyon, France, ^d Osteometer Biotech, Herlev, Denmark

Correspondence to: Dr P Garnero, INSERM Unit 403, Hôpital E Herriot, Pavillon F, 69437 Lyon Cedex 03, France patrick.garnero{at}synarc.com

Accepted for publication 4 January 2001

OBJECTIVETo analyse the relations between the urinary levels of type II collagen C-telopeptide (CTX-II) and glucosyl-galactosyl pyridinoline (Glc-Gal-PYD)two newly developed biochemical markers of type II collagen and synovial tissue destruction respectivelydisease activity and the severity of joint destruction in patients with knee osteoarthritis (OA). The clinical performance of these two new markers was compared with that of a panel of other established biochemical markers of connective tissue metabolism.
METHODSThe following biochemical markers were measured in a group of 67 patients with knee OA (mean age 64 years, median disease duration eight years ) and in 67 healthy controls: for bone, serum osteocalcin, serum and urinary C-telopeptide of type I collagen (CTX-I); for cartilage, urinary CTX-II, serum cartilage oligomeric matrix protein (COMP), and serum human cartilage glycoprotein 39 (YKL-40); for synovium, urinary Glc-Gal-PYD, serum type III collagen N-propeptide (PIIINP), serum hyaluronic acid (HA); and for inflammation, serum C reactive protein. Biochemical markers were correlated with pain and physical function (WOMAC index) and with quantitative radiographic evaluation of the joint space using the posteroanterior view of the knees flexed at 30°.
RESULTSAll bone turnover markers were decreased in patients with knee OA compared with controls (36%, 38%, and 52%, p<0.0001 for serum osteocalcin, serum CTX-I and urinary CTX-I, respectively). Serum COMP (+16%, p=0.0004), urinary CTX-II (+25%, p=0.0009), urinary Glc-Gal-PYD (+18%, p=0.028), serum PIIINP (+33%, p<0.0001), and serum HA (+ 233%, p<0.0001) were increased. By univariate analyses, increased urinary Glc-Gal-PYD (r=0.41, p=0.002) and decreased serum osteocalcin (r=0.30, p=0.025) were associated with a higher total WOMAC index. Increased urinary CTX-II (r=0.40, p=0.0002) and Glc-Gal-PYD (r=0.30, p=0.0046) and serum PIIINP (r=0.29, p=0.0034) were the only markers which correlated with joint surface area. By multivariate analyses, urinary Glc-Gal-PYD and CTX-II were the most important predictors of the WOMAC index and joint damage, respectively.
CONCLUSIONKnee OA appears to be characterised by a systemic decrease of bone turnover and increased cartilage and synovial tissue turnover. CTX-II, Glc-Gal-PYD, and PIIINP may be useful markers of disease severity in patients with knee OA.

---

© 2001 by Annals of the Rheumatic Diseases
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Markers of joint destruction: principles, problems, and potential

S A YOUNG-MIN, T E CAWSTON, and I D GRIFFITHS
Ann Rheum Dis 2001 60: 545-548. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Tabassi, N C.-B., Richardot, P, Toh, L, Marotte, H, Bay-Jensen, A-C, Miossec, P, Garnero, P (2009). Circulating nitrated N-telopeptide of type III collagen (IIINys) as a biochemical marker of oxidative-related synovial tissue metabolism in rheumatoid arthritis. Ann Rheum Dis 68: 451-452 [Full Text]  
• Pollard, T. C. B., Gwilym, S. E., Carr, A. J. (2008). The assessment of early osteoarthritis. J Bone Joint Surg Br 90-B: 411-421 [Abstract] [Full Text]  
• Johansen, J. S., Hoyer, P. E., Larsen, L. A., Price, P. A., Mollgard, K. (2007). YKL-40 Protein Expression in the Early Developing Human Musculoskeletal System. J. Histochem. Cytochem. 55: 1213-1228 [Abstract] [Full Text]  
• Wakitani, S., Nawata, M., Kawaguchi, A., Okabe, T., Takaoka, K., Tsuchiya, T., Nakaoka, R., Masuda, H., Miyazaki, K. (2007). Serum keratan sulfate is a promising marker of early articular cartilage breakdown. Rheumatology (Oxford) 46: 1652-1656 [Abstract] [Full Text]  
• Garnero, P. (2007). New Biochemical Markers of Cartilage Turnover in Osteoarthritis: Recent Developments and Remaining Challenges. IBMS BoneKEy 4: 7-18 [Abstract] [Full Text]  
• Mazzuca, S A, Brandt, K D, Eyre, D R, Katz, B P, Askew, J, Lane, K A (2006). Urinary levels of type II collagen C-telopeptide crosslink are unrelated to joint space narrowing in patients with knee osteoarthritis. Ann Rheum Dis 65: 1055-1059 [Abstract] [Full Text]  
• Bruyere, O, Collette, J, Kothari, M, Zaim, S, White, D, Genant, H, Peterfy, C, Burlet, N, Ethgen, D, Montague, T, Dabrowski, C, Reginster, J-Y (2006). Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study. Ann Rheum Dis 65: 1050-1054 [Abstract] [Full Text]  
• Jordan, K M, Syddall, H E, Garnero, P, Gineyts, E, Dennison, E M, Sayer, A A, Delmas, P D, Cooper, C, Arden, N K (2006). Urinary CTX-II and glucosyl-galactosyl-pyridinoline are associated with the presence and severity of radiographic knee osteoarthritis in men. Ann Rheum Dis 65: 871-877 [Abstract] [Full Text]  
• Mazieres, B, Garnero, P, Gueguen, A, Abbal, M, Berdah, L, Lequesne, M, Nguyen, M, Salles, J-P, Vignon, E, Dougados, M (2006). Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort. Ann Rheum Dis 65: 354-359 [Abstract] [Full Text]  
• Pelloski, C. E., Mahajan, A., Maor, M., Chang, E. L., Woo, S., Gilbert, M., Colman, H., Yang, H., Ledoux, A., Blair, H., Passe, S., Jenkins, R. B., Aldape, K. D. (2005). YKL-40 Expression is Associated with Poorer Response to Radiation and Shorter Overall Survival in Glioblastoma. Clin. Cancer Res. 11: 3326-3334 [Abstract] [Full Text]  
• Savarino, L., Granchi, D., Cenni, E., Baldini, N., Greco, M., Giunti, A. (2005). Systemic cross-linked N-terminal telopeptide and procollagen I C-terminal extension peptide as markers of bone turnover after total hip arthroplasty. J Bone Joint Surg Br 87-B: 571-576 [Abstract] [Full Text]  
• Gineyts, E, Mo, J A, Ko, A, Henriksen, D B, Curtis, S P, Gertz, B J, Garnero, P, Delmas, P D (2004). Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis. Ann Rheum Dis 63: 857-861 [Abstract] [Full Text]  
• Garnero, P, Conrozier, T, Christgau, S, Mathieu, P, Delmas, P D, Vignon, E (2003). Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis. Ann Rheum Dis 62: 939-943 [Abstract] [Full Text]  
• Mouritzen, U, Christgau, S, Lehmann, H-J, Tanko, L B, Christiansen, C (2003). Cartilage turnover assessed with a newly developed assay measuring collagen type II degradation products: influence of age, sex, menopause, hormone replacement therapy, and body mass index. Ann Rheum Dis 62: 332-336 [Abstract] [Full Text]  
• Lehmann, H J, Mouritzen, U, Christgau, S, Cloos, P A C, Christiansen, C (2002). Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products. Ann Rheum Dis 61: 530-533 [Abstract] [Full Text]  
• Dickens, C., McGowan, L., Clark-Carter, D., Creed, F. (2002). Depression in Rheumatoid Arthritis: A Systematic Review of the Literature With Meta-Analysis. Psychosom. Med. 64: 52-60 [Abstract] [Full Text]